ABSTRACT

Stenotrophomonas maltophilia is one of the most frequently isolated multidrug-resistant nosocomial opportunistic pathogens. It contributes to disease progression in cystic fibrosis (CF) patients and is frequently isolated from wounds, infected tissues, and catheter surfaces. On these diverse surfaces S. maltophilia lives in single-species or multispecies biofilms. Since very little is known about common processes in biofilms of different S. maltophilia isolates, we analyzed the biofilm profiles of 300 clinical and environmental isolates from Europe of the recently identified main lineages Sgn3, Sgn4, and Sm2 to Sm18. The analysis of the biofilm architecture of 40 clinical isolates revealed the presence of multicellular structures and high phenotypic variability at a strain-specific level. Further, transcriptome analyses of biofilm cells of seven clinical isolates identified a set of 106 shared strongly expressed genes and 33 strain-specifically expressed genes. Surprisingly, the transcriptome profiles of biofilm versus planktonic cells revealed that just 9.43% ± 1.36% of all genes were differentially regulated. This implies that just a small set of shared and commonly regulated genes is involved in the biofilm lifestyle. Strikingly, iron uptake appears to be a key factor involved in this metabolic shift. Further, metabolic analyses implied that S. maltophilia employs a mostly fermentative growth mode under biofilm conditions. The transcriptome data of this study together with the phenotypic and metabolic analyses represent so far the largest data set on S. maltophilia biofilm versus planktonic cells. This study will lay the foundation for the identification of strategies for fighting S. maltophilia biofilms in clinical and industrial settings.
IMPORTANCE Microorganisms living in a biofilm are much more tolerant to antibiotics and antimicrobial substances than planktonic cells are. Thus, the treatment of infections caused by microorganisms living in biofilms is extremely difficult. Nosocomial infections (among others) caused by S. maltophilia, particularly lung infection among CF patients, have increased in prevalence in recent years. The intrinsic multidrug resistance of S. maltophilia and the increased tolerance to antimicrobial agents of its biofilm cells make the treatment of S. maltophilia infection difficult. The significance of our research is based on understanding the common mechanisms involved in biofilm formation of different S. maltophilia isolates, understanding the diversity of biofilm architectures among strains of this species, and identifying the differently regulated processes in biofilm versus planktonic cells. These results will lay the foundation for the treatment of S. maltophilia biofilms.

INTRODUCTION

Immunocompromised patients suffer a high risk of nosocomial bacterial infections. These infections are mostly caused by opportunistic bacterial pathogens. Stenotrophomonas maltophilia is a Gram-negative bacterium and belongs to the Gammaproteobacteria. The role of S. maltophilia as a causative agent of infection remains unclear, and its pathogenicity is not yet fully understood. Nonetheless, S. maltophilia is today recognized as a clinically relevant human opportunistic pathogen that has been associated with a series of infections, such as respiratory tract infection, surgical site infections, peritonitis, endocarditis, bacteremia, and implant-associated infections (13). S. maltophilia together with other major pathogens, such as Staphylococcus aureus, nontuberculous Mycobacterium, Pseudomonas aeruginosa, or Burkholderia cenocepacia, can contribute to severe pulmonary infections in cystic fibrosis (CF) patients (4, 5). The prevalence of S. maltophilia in nosocomial infections, particularly lung infections among CF patients, has increased in the last years, and its intrinsic resistance to a broad spectrum of antibiotics makes this organism a relevant multidrug-resistant pathogen in hospitalized patients (1, 6, 7). S. maltophilia exhibits a high level of intraspecies genomic and phenotypic diversity (810). Analysis of the globally collected genomes of 1,305 isolates from 22 nations indicated that at least 23 phylogenetically distinct lineages can be observed within the S. maltophilia species (11).
S. maltophilia, like most bacterial pathogens, can adhere and form biofilms on host tissues, such as the respiratory tract and skin, as well as on abiotic surfaces, such as medical devices and implants, and it can cause severe infections (1214). It is well known that bacterial biofilms provide a shield against antibiotic treatment as well as host defense systems and therefore play a major role in chronic infections (15, 16). Recently, a few molecular keys have been affiliated with S. maltophilia biofilm formation. Among those is the quorum sensing system, which is mediated by the diffusible signal factor (DSF) (17, 18), cell motility (19), and genes involved in lipopolysaccharide/exopolysaccharide biosynthesis (20, 21). In further studies, iron availability was shown to play an essential role in biofilm formation (22, 23).
Within this framework and with respect to the observed genome diversity (11, 24), we asked to what extent genomic diversity affects common phenotypes. Focusing mainly on the biofilm properties of S. maltophilia, we assayed biofilm phenotypes and proteolytic and virulence profiles of selected isolates and correlated these findings with deep RNA transcriptomic data.
Our data provide insights into the biofilm architecture and heterogeneity on the species level. Additional transcriptome data of seven clinical isolates identified major genetic loci differentially expressed in S. maltophilia biofilms. Our findings indicate that a rather small number of genes (9.43% ± 1.36%) are involved in the different lifestyles of biofilm cells compared to planktonic cells.

RESULTS AND DISCUSSION

High phenotypic variability at a strain-specific level in S. maltophilia.

(i) S. maltophilia biofilm formation capabilities vary strongly at a strain-specific level. Few studies have analyzed the biofilm formation and profiles of S. maltophilia (22, 25). To broaden this approach, we have analyzed the capabilities of 300 clinical and environmental isolates from different European countries to form biofilms (see Table S1 in the supplemental material). Of the tested isolates, 261 were of clinical origin and 39 were of environmental origin. All strains were able to adhere and form biofilms on microtiter plates after 24 h of incubation. Based on the microtiter plate biofilm assay, 14.3% of all the investigated isolates formed strong biofilms, 77.0% formed moderate biofilms, and 8.7% formed weak biofilms (Fig. 1). Thus, biofilm formation varied greatly at a strain-specific level. The relative biofilm optical density (OD) values differed by a factor of almost 14. Interestingly, the commonly used model organism, isolate K279a, was just a moderate biofilm former. With a relative biofilm OD value of 0.211, it was categorized as the second-to-last biofilm former within the category of the moderate biofilm formers.
FIG 1
FIG 1 High strain-specific variation with respect to biofilm formation of 300 clinical and environmental isolates of S. maltophilia. Biofilm forming abilities were analyzed in microtiter plates using the crystal violet stain method. Clinical isolates were grown at 37°C (solid bars) and environmental isolates at 28°C (striped bars) for 24 h. Clinical strains PEG 13-85-49 (A), 454* (B), ICU331* (C), SKK55* (D), K279a (E), 677* (F), PC239* (G), PC240* (H), PEG 13–68-68* (I), PEG 13-2-40 (J), and PEG 13-106-64 (K) are highlighted. The last two formed the strongest biofilms. B to D and F to I were included in the transcriptome and other analyses. K279a (E) was included as a control strain. The relative biofilm formation for 6 technical replicates is illustrated. Strains are positioned from low to strong biofilm formers. OD values of relative biofilm formation ranged from 0.064 to 0.88. Isolates with a relative biofilm OD of ≤0.2 were classified as weak biofilm formers (green), and all isolates with a relative biofilm OD of ≥0.5 were classified as strong biofilm formers (red). All isolates with a relative biofilm OD between 0.2 and 0.5 were classified as moderate biofilm formers (orange). Standard deviations ranged from 0.003 to 0.098. Strains employed in transcriptome and virulence analyses are indicated with asterisks. Coordinates of all isolates together with their metadata are listed in Table S1.
Notably, we did not observe a relationship between biofilm formation capabilities and the origin of isolation. This concerned environmental as well as clinical isolates. Furthermore, no correlation was observed with respect to the phylogenetic position of the isolates within 1 of the 23 recently discovered lineages of the S. maltophilia species (11).
(ii) High variability in biofilm architecture formed by S. maltophilia. Acknowledging the various biofilm forming abilities of individual S. maltophilia strains, we went on to systematically evaluate the architecture of the biofilms of clinical S. maltophilia. Therefore, 40 isolates were chosen from the categories weak, moderate, and strong biofilm formers based on the results of our static biofilm assay in microtiter plates (Fig. 1). This analysis further confirmed the high level of strain-specific heterogeneity. Each strain produced a very distinct biofilm architecture, with some showing clear signs of multicellularity (Fig. 2). The architectures observed were categorized into either flat, patchy, rough, or filamentous biofilms. Of the 40 analyzed strains, 16 isolates formed flat (40%), 8 isolates formed patchy (20%), 14 isolates formed rough (35%), and 2 isolates formed filamentous (5%) biofilms. The observed architectures did not differ significantly when strains were grown in flow cells or in static systems. The biofilms ranged in thickness from 2.9 μm (PEG 13-80-49) to 63.6 μm (PEG 13-25-38). Using a LIVE/DEAD stain, the biofilm-grown cells appeared to be viable in most cases. However, a large number of cells of the strains PEG 13-101-78 and PEG 13-64-34 appeared to be dead (Fig. 2A). No relationship between the biofilm architecture of the individual strains and their origin of isolation, their phylogenetic position within the species, or their classification as strong, moderate, or weak biofilm formers was detected. Remarkably, isolate 454 formed dense clusters of cells that appeared to have a rosette-like structure (Fig. 2B and C).
FIG 2
FIG 2 High-level architectural heterogeneity in 40 different clinical S. maltophilia isolates. Biofilm cells were grown under flow or static conditions for 72 h. After a LIVE/DEAD staining, the biofilm architectures were recorded using CLSM. Red, dead cells; green, living cells. (A) The isolates were grouped as forming flat, rough, patchy, and filamentous biofilms based on their overall architectures. Strain identifiers are indicated on the top left corner for each isolate. Strains used in additional transcriptome data are marked with an asterisk. Images represent an area of 100 μm by 100 μm of the respective biofilm. For each of the 40 isolates, at least 3 areas were analyzed. (B) Multicellular and filamentous forms of the isolates PC256 and PEG 13-25-38 are shown via a top view on the biofilm architecture. Scale bar represents 10 μm. (C) Isolate 454 forms rosette-like multicellular clusters of cells. In the right panel, a 4-fold magnification of the boxed area of the left panel is depicted. Scale bar represents 10 μm.
Until now, only a limited number of studies have shown diversity in biofilm architectures among strains of the same bacterial species. A study on the biofilm architectures of 96 Listeria monocytogenes isolates showed variations in biofilm architectures, with a particular predominant morphotype, the honeycomb-like morphotype. However, just like in our observations, there was no correlation between the biofilm architectures and the genetic lineages of the different isolates (26, 27). Furthermore, Hornischer et al. generated a reference database for Pseudomonas aeruginosa and reported on large strain-specific variations with respect to resistance, virulence, and biofilm architecture (https://bactome.helmholtz-hzi.de) (28).

Proteolytic and virulence profiles differ largely at a strain-specific level.

Knowing that extracellular proteases are associated with virulence of pathogenic bacteria, including S. maltophilia (2931), and that extracellular proteolytic activity has been associated with biofilm formation in some bacterial species (32), we further asked to what extent the extracellular proteolytic activities of the different isolates differ at a strain-specific level. Therefore, we profiled the extracellular proteolytic activities of several S. maltophilia strains. As assumed, the different strains displayed different levels of protease activity in planktonic as well as in biofilm cultures. Surprisingly, extracellular protease activity was up to 40 times higher in biofilm cultures than in planktonic cultures (Fig. 3A). However, no correlation between biofilm forming capabilities and the phylogenetic origin within the species was observed.
FIG 3
FIG 3 Protease activity and virulence degree vary at a strain-specific level. (A) The extracellular protease activities in biofilm (dark gray) and planktonic (light gray) cultures of 22 clinical isolates were determined in microtiter plates using the EnzCheck protease assay kit. Error bars indicate standard deviations of 3 independent biological replicates. Strains employed in transcriptome and virulence analyses are indicated by an asterisk. (B) The degrees of virulence of S. maltophilia SKK55 (red), 454 (green), ICU331 (black), 677 (gray), PC240 (ochre), PC239 (orange), and PEG 13-68-68 (purple) were tested by recording the survival of Galleria mellonella. PBS (blue) was used as a control. Mortality events were recorded at 24, 48, and 72 h postinfection. FU, fluorescence units.
In the light of the above-described observations, we also asked to what extent S. maltophilia isolates differ in their strain-specific virulence patterns. Therefore, we investigated the virulence of seven isolates using the Galleria mellonella model. The 7 isolates were chosen based on their different biofilm architectures, ranging from flat to patchy and rough with filaments. In these tests, we showed that an infection dose of 1 × 105 CFU/larva of the different strains caused a different mortality outcome in G. mellonella larvae. Strain 454 appeared to be most virulent, with only 37.5% of larvae surviving after a 72-h incubation period (Fig. 3B). In contrast, strain 677 showed the least virulence, with 100% survival of larvae after 72 h. The high heterogeneity in virulence of S. maltophilia isolates demonstrated in this study has also been shown in other studies (33, 34). We did not observe a correlation between biofilm profiles, biofilm architectures of these isolates, and their degrees of virulence using the G. mellonella model. However, since we analyzed only seven isolates with respect to their virulence in the G. mellonella model, we cannot exclude that a larger analysis will show that other strains might be more virulent.

Global transcriptome sequencing (RNA-seq) indicates a set of 106 shared highly expressed genes in S. maltophilia biofilms and not more than 33 strain-specific genes.

To obtain a comprehensive overview of all genes that could possibly play an important role in mature S. maltophilia biofilms, we analyzed the transcriptomes of the same seven clinical S. maltophilia isolates as employed in the Galleria mellonella model (Table 1 and Table S1). The isolates were chosen because they differed in their biofilm architectures (Fig. 2). We first analyzed the transcriptomes of 72-h-old biofilms to identify the most relevant biofilm-expressed genes. We then compared these data sets with transcriptomes of planktonic cultures of the same isolates. Using these comprehensive data sets, we asked three main questions. First, which are the most strongly expressed genes in mature biofilms in general, and what are the main metabolic routes in these biofilms? Second, which are the strain-specifically expressed genes that contribute to the highly heterogeneous biofilm architectures? Third, which are the regulated but commonly expressed genes under biofilm versus planktonic conditions?
TABLE 1
TABLE 1 Key traits of S. maltophilia clinical isolates included in transcriptome analyses of biofilm and planktonic cells
StrainLineage within the speciesaGenome size
(Mbp/ORFsb)
RNA seq (avg total mapped reads)cBiofilm architecture/attachment to microtiter platesNo. of genes regulated in biofilm vs planktonic cellsdMortality of G. mellonella (%)
BiofilmPlanktonic
SKK55Sm34.6/4,29623,272,78427,299,628Rough/weak284 ↑/34 ↓20
ICU331Sm65.0/4,71624,714,06928,763,824Patchy/weak398 ↑/37 ↓7
677Sm64.7/4,43322,400,7658,600,306Flat/moderate421 ↑/116 ↓0
454Sm64.6/4,26924,759,88827,668,615Patchy/weak338 ↑/67 ↓63
PC239Sm4a4.6/4,34925,599,9368,494,898Flat/moderate240 ↑/148 ↓27
PC240Sm4a4.8/4,35028,690,7809,845,647Rough/moderate263 ↑/154 ↓20
PEG 13-68-68Sm64.5/4,09424,941,7949,037,393Rough/moderate359 ↑/57 ↓39
a
The genomes of the S. maltophilia isolates were previously sequenced, and pangenome analyses implied that they shared 3,800 orthologous genes/functions with the reference strain K279a (11).
b
ORFs, open reading frames.
c
The raw reads of the 42 mRNA sequencing runs have been deposited at the SRA nucleotide archive (see Materials and Methods).
d
↑, upregulated; ↓, downregulated.
(i) S. maltophilia strongly expressed genes in biofilms give insight into metabolism and life on surfaces. In general, each strain transcribed between 4,000 and 4,350 genes under biofilm conditions (Table S3). It is noteworthy that the genome sizes of the seven isolates varied slightly (Table 1). Using a nucleotide activities per kilobase of exon model per million mapped reads (NPKM) cutoff of 10, in general, 80.5% of all genes were transcribed to some extent under the biofilm conditions (Table S3).
To identify the most relevant and strongly expressed genes in biofilm-grown cells, we decided to focus on the top 250 expressed genes (excluding ribosomal proteins) in our analyses (Table S4). This arbitrarily chosen cutoff correlated in all strains with the expression level of the rpoD gene, which is used in many studies as a reference gene (35, 36). This initial analysis included all strongly expressed genes, independent of whether these were regulated or constitutively expressed in biofilm versus planktonic cells. A Venn analysis revealed that 42% (106 genes) of the top 250 biofilm-expressed genes were commonly expressed among all isolates (Tables 2 and 3). Thus, the shared set of 106 commonly expressed genes build a core set of biofilm-expressed genes. These genes are all part of the core genome of the seven isolates.
TABLE 2
TABLE 2 Shared expressed genes (regulated and nonregulated) among the top 250 expressed genes in the seven analyzed S. maltophilia clinical isolates
Predicted function454 locus tag
(NIPOLPBK no.)a
Transcription/translation 
    Division/cell wall cluster transcriptional repressor MraZ01488
    Flagellar biosynthesis anti-sigma factor FlgM03920
    DNA-binding response regulator00616
    RNA polymerase sigma factor RpoD; RpoH01893; 01985
    HU family DNA-binding protein02561
    DNA-directed RNA polymerase subunit beta′; beta04131; 04132
    RNA polymerase-binding protein DksA01317
    Elongation factor Ts; P00051; 01310
    O-Acetyl-ADP-ribose deacetylase03022
    Polyribonucleotide nucleotidyltransferase03547
    DNA recombination/repair protein RecA04177
    DNA starvation/stationary phase protection protein03142
    Adenosylhomocysteinase01517
Iron aquisition 
    TonB-dependent receptor03236
    Energy transducer TonB02458; 01378
Bacterioferritin03836
Membrane proteins/transporters 
    Porin03489
    MotA/TolQ/ExbB proton channel family protein02457
    DNA transport competence protein ComEA00199
    Biopolymer transporter ExbD02455; 02456
    Cation transporter03486
    Preprotein translocase subunit SecY; SecE03720; 04138
    OmpA family lipoprotein03078
    OmpW family protein01780
    PTS fructose transporter subunit IIA02219
    Peptidoglycan-associated lipoprotein Pal03125
    Tol-Pal system protein YbgF03126
    Membrane protein03745; 00399; 02118
    Glycine zipper 2TM domain-containing protein01412; 01407; 02726
    Ax21 family protein02718; 00668
Hypothetical proteins/proteins of unknown function 
    Tetratricopeptide repeat protein02459
    FAD-binding protein00093
    CBS domain-containing protein00424
    Hypothetical protein01390; 03621; 03092;
03497; 00615; 00732;
03808; 03451; 02369;
01049; 01025; 02370
Stress response 
    Superoxide dismutase01384
    Universal stress protein00791
    Cold shock protein02817; 03799
    Peroxiredoxin03154
    PAS sensor domain-containing protein03584
Pathogenicity 
    Entericidin, EcnA/B family00629
Respiration/energy 
    Cytochrome bd oxidase subunit I; II01342; 01341
    ATP synthase subunit alpha; beta; B00409; 00411; 00407
    ATP synthase epsilon chain00412
    Cytochrome bd-I oxidase subunit CydX01340
    Adenylate kinase01697
    Azurin01710
    Thioredoxin01991
    Hemerythrin01154
    Protein processing/modification/proteolysis 
    Molecular chaperone DnaK; GroEL; GroES03046; 01940; 01941
    FKBP-type peptidyl-prolyl cis-trans isomerase01169
    Peptidylprolyl isomerase03733
    Trigger factor02566
    ATP-dependent metallopeptidase FtsH/Yme1/Tma family protein01006
    ATP-dependent Clp protease ATP-binding subunit ClpX02564
    ATP-dependent Clp protease proteolytic subunit02565
Metabolism/biosynthesis 
    Glutamate dehydrogenase03266
    2-Oxoglutarate dehydrogenase E1 component01425
    Pyruvate dehydrogenase (acetyl-transferring), homodimeric type03384
    Lysine decarboxylase03487
    Succinate dehydrogenase flavoprotein subunit03646
    Methylmalonate-semialdehyde dehydrogenase (CoA acylating)00557
    Dihydrolipoyl dehydrogenase01423
    Oxygen-independent coproporphyrinogen III oxidase01044
    Citrate synthase01750
    Dihydrolipoyllysine residue succinyltransferase01424
    Succinyl-CoA ligase subunit beta02984
    Acyl-CoA dehydrogenase00558
    Polyketide cyclase00315
    Alcohol dehydrogenase AdhP02422
    Type I glyceraldehyde-3-phosphate dehydrogenase01781
    Fructose-bisphosphate aldolase class I03024
    Isocitrate dehydrogenase02640
    Malate dehydrogenase03734
    Phenylalanine 4-monooxygenase02418
    Succinate-CoA ligase subunit alpha02983
    Inorganic diphosphatase01682
    Acyl carrier protein02130
Cell division 
    Cell division protein FtsZ01501
a
Locus tags refer to the gene designations GenBank file CP060027 for the isolate 454.
TABLE 3
TABLE 3 Strain-specific expressed genes (regulated and nonregulated) among the top 250 expressed genes in the seven different S. maltophilia clinical isolates analyzed
Isolate and locus tagaPredicted function
S. maltophilia isolate 454 
    NIPOLPBK_03560MerR family transcriptional regulator
    NIPOLPBK_03053Outer membrane protein assembly factor BamE
    NIPOLPBK_03052Ferric iron uptake transcriptional regulator
    NIPOLPBK_02989Pilin
    NIPOLPBK_03740Cell wall hydrolase
    NIPOLPBK_02530C4-dicarboxylate transporter
    NIPOLPBK_03692Membrane protein
    NIPOLPBK_03349; NIPOLPBK_00082ABC transporter ATP-binding protein
    NIPOLPBK_02384DNA-binding response regulator
    NIPOLPBK_02881Elongation factor G
    NIPOLPBK_00124TonB-dependent siderophore receptor
    NIPOLPBK_03559Integration host factor subunit alpha
    NIPOLPBK_02127Serine/threonine protein kinase
    NIPOLPBK_00518Thiol:disulfide interchange protein DsbA/DsbL
    NIPOLPBK_01192STAS domain-containing protein
    NIPOLPBK_01113Monothiol glutaredoxin, Grx4 family
    NIPOLPBK_00840SH3 domain-containing-like protein 1
    NIPOLPBK_00961IS1595 family transposase ISAcif2
    NIPOLPBK_01249MexC, transporter periplasmic subunit
    NIPOLPBK_03905Flagellin
    NIPOLPBK_02388Peptide-methionine (R)-S-oxide reductase
S. maltophilia isolate 677 
    FLFIOBJN_01112Acetyl-CoA carboxylase biotin carrier protein
    FLFIOBJN_02765NADP-dependent malic enzyme
    FLFIOBJN_04431Flagellin
    FLFIOBJN_00592Succinate dehydrogenase iron-sulfur subunit
    FLFIOBJN_01823NADH-quinone oxidoreductase subunit K
    FLFIOBJN_01373GNAT family N-acetyltransferase
    FLFIOBJN_03492Single-stranded DNA-binding protein
    FLFIOBJN_01536dTDP-glucose 4,6-dehydratase
    FLFIOBJN_01537Glucose-1-phosphate thymidylyltransferase
    FLFIOBJN_01538dTDP-4-dehydrorhamnose 3,5-epimerase
    FLFIOBJN_01823NADH-quinone oxidoreductase subunit G
    FLFIOBJN_01257Methylisocitrate lyase
    FLFIOBJN_01869Peptidase
    FLFIOBJN_02323Bifunctional proline dehydrogenase/l-glutamate gamma-semialdehyde dehydrogenase PutA
    FLFIOBJN_01081NADP-dependent isocitrate dehydrogenase
S. maltophilia isolate SKK55 
    GPNADHDJ_01778Prepilin-type cleavage protein
    GPNADHDJ_02908Transcription elongation factor GreA
    GPNADHDJ_01676Enolase
    GPNADHDJ_01978PhoH family protein
    GPNADHDJ_02891Long-chain fatty acid-CoA ligase
    GPNADHDJ_03134; GPNADHDJ_03863Acyl-CoA dehydrogenase
    GPNADHDJ_03866TonB-dependent receptor
    GPNADHDJ_02768Cell division protein, ZapA
    GPNADHDJ_019754-hydroxy-tetrahydrodipicolinate synthase
    GPNADHDJ_03864Alpha/beta hydrolase
    GPNADHDJ_04044Acetyl-CoA C-acyltransferase
    GPNADHDJ_01835Sulfoxide reductase catalytic subunit YedY
    GPNADHDJ_03735Cupin domain-containing protein
    GPNADHDJ_02081Fe-S biogenesis protein NfuA
    GPNADHDJ_00856Ax21 family protein
    GPNADHDJ_01207ParA family protein
    GPNADHDJ_02348DNA-binding response regulator
    GPNADHDJ_01752Oar protein
S. maltophilia isolate ICU331 
    EIELFIGP_03830Fis family transcriptional regulator
    EIELFIGP_00484Membrane protein
    EIELFIGP_00483EamA family transporter
    EIELFIGP_03092ACR protein
    EIELFIGP_04252IMP dehydrogenase
    EIELFIGP_01515Translational throttle protein EttA
    EIELFIGP_00265RNA helicase
    EIELFIGP_02438AcrB/AcrD/AcrF family protein
    EIELFIGP_03678TonB-dependent receptor
    EIELFIGP_03829Type II toxin-antitoxin RelE/ParE family toxin
    EIELFIGP_01306S-Adenosylmethionine decarboxylase proenzyme
    EIELFIGP_01865FoF1 ATP synthase subunit A
    EIELFIGP_04217Transcriptional regulator
    EIELFIGP_03352Aspartate-semialdehyde dehydrogenase
    EIELFIGP_03290Flagellin
    EIELFIGP_03291Flagellin
S. maltophilia isolate PC239 
    PLCFDHLH_00300Transcriptional regulator
    PLCFDHLH_01540Classical arabinogalactan protein 4
    PLCFDHLH_01650Helix-turn-helix domain-containing protein
    PLCFDHLH_04366Penicillin-binding protein activator
    PLCFDHLH_03625Dihydrolipoyllysine-residue acetyltransferase
    PLCFDHLH_03306Iron-sulfur cluster assembly accessory protein
    PLCFDHLH_03284methyltransferase domain-containing protein
    PLCFDHLH_03397Fimbrial biogenesis outer membrane usher protein
    PLCFDHLH_04557IS3 family transposase
S. maltophilia isolate PC240 
    IMCGPPIG_03647RidA family protein
    IMCGPPIG_02449GlsB/YeaQ/YmgE family stress response membrane protein
    IMCGPPIG_00866TonB-dependent receptor
S. maltophilia isolate PEG 13-68-68 
    AEPCKKLL_01703Polyketide cyclase
    AEPCKKLL_03165Pilin
    AEPCKKLL_02474Molybdopterin molybdenum transferase MoeA
    AEPCKKLL_03864Flagellar hook protein FliD
    AEPCKKLL_02476Molybdopterin converting factor subunit 2 protein
    AEPCKKLL_00278Ubiquinone/menaquine biosynthesis C-methyltransferase UbiE
    AEPCKKLL_01787TonB-dependent receptor
a
Locus tags refer to the GenBank files: SKK55, CP060025; ICU331, CP060026; 677, CP060024; 454, CP060027; PC239, CP060023; PC240, CP060022; and PEG13-68-68, CP060021. Hypothetical proteins are not included.
A more detailed functional analyses indicated that among the 106 shared genes, the largest fractions were assigned to metabolism (20.75%), to membrane proteins and transporters (19.81%), and to transcription and translation (15.09%) (Fig. 4A and Table 2).
FIG 4
FIG 4 Global transcriptome analysis of seven biofilm-grown S. maltophilia isolates, SKK55, 454, ICU331, 677, PC240, PC239, and PEG 13-68-68. (A) Functional distribution of the 106 commonly expressed genes (regulated and not regulated) among the top 250 strongly expressed genes in the biofilms of the seven clinical isolates (Table 2). Expression data were extracted from global RNA-seq analyses, and the top 250 strongly expressed genes are listed in Table S4. (B) Mean fold change in relation to the NPKM value of the housekeeping gene rpoD. Error bars indicates standard deviations and are based on three independent biological replicates.
Surprisingly, all strains expressed a gene coding for the alcohol dehydrogenase AdhP at a high level, up to 38 times higher than the expression level of the housekeeping gene rpoD (Fig. 4B). In Escherichia coli, AdhP is probably involved in the production of propanol, or similar short-chain alcohols, under biofilm conditions (37). Since this enzyme belongs to the alcohol dehydrogenase superfamily, we speculate that it is further involved in the production of various short-chain alcohols in S. maltophilia. In this respect, it had not been reported that S. maltophilia produces primary or secondary alcohols. Therefore, we analyzed the supernatants of biofilm and planktonic cultures using 1H nuclear magnetic resonance (NMR). The NMR data indicated that biofilm-grown cells produced micromolar amounts of 1- and 2-propanol as well as acetate together with several unknown compounds (Table 4 and Fig. S1). These short-chain alcohols were not observed in any of the planktonic cultures. The occurrence of the different alcohols, however, varied at a strain-specific level.
TABLE 4
TABLE 4 Chemical compounds identified in biofilm and planktonic culture supernatants of seven different S. maltophilia clinical isolates
IsolateGrowth conditionCompound detected and verifieda
1-Propanol2-PropanolThreonineAcetateEthanol
SKK55BiofilmXXX_X
Planktonic____X
ICU331Biofilm__XXX
Planktonic___X_
454Biofilm_XXXX
Planktonic___X?
677Biofilm__XXX
Planktonic__XXX
PC239Biofilm__XXX
Planktonic__X__
PC240BiofilmXXXXX
Planktonic_____
PEG 13-68-68Biofilm__XXX
Planktonic____X
a
Representative spectra of the different compounds in the supernatants are given in Fig. S1. X, detected/verified; -, not detected/verified.
Furthermore, it is noteworthy that the genes coding for a Pal protein together with the YgbF protein were strongly transcribed in all seven characterized strains. The Pal protein is part of the Tol-Pal complex and is involved in cell envelope-related processes. It is involved in transport processes but also in release of outer membrane vesicles and cell septum formation (38) and has been associated with survival and pathogenesis in bacteria (39).
Among the other most relevant genes, many are involved in iron uptake, such as the gene coding for the biopolymer transporter ExbD. Moreover, all strains expressed genes of the ATP-dependent Clp protease complex, which is commonly involved in proteolysis and regulation of different metabolic processes. Interestingly, some studies have shown that the Clp protease complex also plays a role in biofilm formation and virulence in Listeria monocytogenes and Actinobacillus pleuropneumoniae (40, 41).
The gene encoding the DNA transport competence protein ComEA was strongly expressed in all seven isolates. ComEA is essential for DNA transport and bacterial competence (42). We have recently identified the comEA locus as potentially involved in phenotypic heterogeneity in S. maltophilia (10). The observation that comEA is highly expressed may suggest a broader role in S. maltophilia biofilm formation (43).
(ii) Genes strongly expressed at a strain-specific level give the first clues on heterogeneous phenotypes. Altogether, 142 of the 250 most strongly expressed genes seemed to be strain-specifically expressed in only one of the seven analyzed isolates. While strain PC240 expressed only five genes at a strain-specific level, 454, the most virulent strain (Fig. 3B), expressed 33 genes at a strain-specific level (Table 3). While we initially hoped that these data would give us clues about the different biofilm architectures, the data did not allow for a final conclusion on these highly diverse biofilm phenotypes. Nevertheless, some of the observed differential expression profiles may in part provide the first clues about the high strain-specific variability.
For instance, SKK55 biofilms and some others consisted of a remarkable number of multicellular structures, such as long filamentous cells (Fig. 2). The zapA gene was one of 30 strain-specific genes of SKK55 (Table 3), which is involved in cell division (4446). The elevated expression of the mraZ gene has been linked to the occurrence of filamentous cells in E. coli and Mollicutes (47, 48). The observation made in this study may explain the frequent occurrence of filamentous cells in S. maltophilia SKK55 biofilms.
(iii) Relatively few genes may play a role in matured biofilms of S. maltophilia. In addition to comparing the transcriptomes of the seven S. maltophilia isolates under biofilm conditions, we also compared biofilm and planktonic cells for each isolate (Fig. S2). Generally, under planktonic conditions, 96.9% of all genes were transcribed (NPKM value > 0) (Table S5) and 3.0% were not transcribed in all seven strains. Remarkably, the majority of the top 250 strongly expressed genes in biofilms were equally highly expressed in planktonic cultures. These were often essential genes involved in general and aerobic metabolism (Tables S4 and S6).
Comparing the biofilm-expressed genes with the planktonic expressed genes in detail, we noted that just 9.43% ± 1.36% of all genes were differentially regulated, consisting of 7.46% ± 1.49% upregulated genes and 1.96% ± 1.02% downregulated genes using log2 fold change cutoffs of 2 and −2 and a P adjusted (Padj) value of ≤0.05 (Fig. 5 and Table 1). In general, between 240 and 421 genes were upregulated and between 34 and 154 genes were downregulated when we compared the planktonic with the biofilm cells (Table 1).
FIG 5
FIG 5 Differentially expressed genes between biofilm and planktonic cells of clinical S. maltophilia isolates. Shown are volcano plots of differentially expressed genes between biofilm and planktonic cells of S. maltophilia 454 (A), ICU331 (B), SKK55 (C), 677 (D), PC239 (E), PC240 (F), and PEG 13-68-68 (G). The 8 strongest commonly upregulated genes in all isolates are indicated by numbers as follows: 1, hypothetical protein (NIPOLPBK_02286); 2, PAS sensor domain-containing protein (NIPOLPBK_03584); 3, TonB-dependent receptor (NIPOLPBK_02287); 4, hemin uptake protein HemP (NIPOLPBK_01535); 5, sulfite reductase flavoprotein alpha subunit (NIPOLPBK_03585); 6, TetR/AcrR family transcriptional regulator (NIPOLPBK_02786); 7, cytochrome b (NIPOLPBK_03926); and 8, flagellin (NIPOLPBK_03906). Locus tags were derived from the 454 genome entry CP060027 and homologues retrieved from the corresponding genomes of the other isolates (see Table 1 for GenBank accession numbers). Genes without significant regulation (Padj > 0.05 [gray]), genes with Padj of <0.05 (blue), and significantly up- or downregulated genes (Padj < 0.05; log2 fold change of greater than 2 or less than −2 [red]) are illustrated. For isolate 454, 338 genes were upregulated of a total gene count of 4,269 genes, while 67 genes were downregulated. Of a total of 4,716 genes, 398 genes were upregulated and 37 genes were downregulated in ICU331. For SKK55, 284 genes were upregulated and 34 genes were downregulated of a total of 4,296 genes. In 677, 421 of 4,433 genes were upregulated, while 116 were downregulated. For PC239, 240 genes were upregulated and 148 genes were downregulated of a total of 4,564 genes. Of a total of 4,564 genes, 262 genes were upregulated and 153 genes were downregulated in PC240. For PEG 13-68-68, 359 genes were upregulated and 57 genes were downregulated of a total of 4,094 genes. Normalized gene read counts were used to build volcano plots.
A pangenome analysis of all seven isolates identified the gene clusters present in the core genome (Fig. 6). The integration of the log2 fold change values of all up- and downregulated genes into the pangenome analysis revealed that 68% ± 8% of all regulated genes belong to the core genome. A Venn analysis of all gene clusters of the regulated genes generated by the pangenome analysis identified 52 genes that were commonly upregulated and 1 gene (5S rRNA) that was commonly downregulated in all isolates (Table 5). The largest fraction of the commonly upregulated genes coded for hypothetical and uncharacterized proteins (30.8%), followed by genes involved in transcription and translation (17.3%) (Fig. 7). A remarkably high number of genes involved in iron acquisition (11.5%) were found to be upregulated in almost all seven analyzed S. maltophilia isolates (Fig. 7 and Table S7).
FIG 6
FIG 6 Pangenome and differential gene expression analysis of seven clinical S. maltophilia isolates. Comparative Anvi’o pangenome analysis of seven clinical S. maltophilia isolates combined with differential gene expression of biofilm versus planktonic cells of these isolates was conducted. The dendrogram in the center represents the relationship between 5,881 gene clusters (GCs) involving 30,168 gene calls. The seven inner layers represent individual genomes, which are compared to each other. In the layers, black indicates the presence of gene clusters and gray their absence. The genomes are organized regarding the presence/absence of GCs as indicated by the phylogenetic tree in the top right. The red layer represents the single gene copy (SCG) clusters, in which dark red indicates the presence and light red the absence of SCG clusters. The next seven layers represents the log2 fold change of gene clusters differently regulated in biofilm versus planktonic cells of individual isolates. The dark gray sublayer indicates the downregulated gene clusters and the light gray ones the upregulated gene clusters in biofilm cells, respectively. The core (blue) and accessory genomes (green) are indicated in the next layer. In the outermost layer, some interesting regions are highlighted (A and B). (A) Hypothetical protein (NIPOLPBK_02286 in strain 454). (B) Among others, several nitrate assimilation-related genes. The right-hand side section reveals the genome length, the GC content, the number of gene clusters present in just one genome, the total gene cluster number, and the proportions of up- and downregulated genes for each isolate.
TABLE 5
TABLE 5 Commonly up- and downregulated genes in biofilm versus planktonic cultures of seven S. maltophilia clinical isolates
Predicted function454 locus tag (NIPOLPBK no.)aLog2 fold change
Commonly upregulated genes  
    Transcription/translation  
        TetR/AcrR family transcriptional regulator027865.26
        Ribosomal subunit interface protein022203.62
        Glycine cleavage system regulatory protein036194.56
        30S ribosomal protein S4037234.17
        DNA-binding transcriptional regulator Fis019724.94
        YncE family protein028873.70
        Transcriptional regulator012124.22
        Zinc finger domain-containing protein025343.93
        Ribonucleotide diphosphate reductase subunit beta020595.45
    Iron acquisition  
        TonB-dependent receptor02380; 022872.30; 6.38
        Hemin uptake protein HemP015355.06
        Iron-regulated lipoprotein034835.89
        Energy transducer TonB018485.44
        TonB-dependent receptor029722.69
    Membrane proteins/transporters  
        Glycine zipper 2TM domain-containing protein027265.60
        PTS fructose transporter subunit IIA; IIBC02219; 015964.10; 2.62
        Lysine transporter LysE003005.48
        Carbohydrate porin015974.10
        Hypothetical proteins/proteins of unknown function  
        Hypothetical protein01621; 02971;
01805; 03497;
00009; 00662;
03451; 02369;
00474; 00227;
01538; 03808; 02285; 01411; 03807; 02286
2.36; 2.48;
2.18; 2.86;
8.03; 2.50;
3.40; 3.98; 3.75; 4.24;
2.80; 5.12; 5.92; 5.85; 4.68; 10.57
    Pathogenicity  
        Putative protein YqiC037804.62
    Respiration/energy  
        Cytochrome b039263.20
        FMN reductase016202.34
        Ferredoxin-NADP reductase013952.34
        NADH-quinone oxidoreductase subunit A035254.68
    Stress response  
        PAS sensor domain-containing protein035849.29
        Peroxiredoxin033215.48
    Protein processing/modification/proteolysis  
        Copper chaperone012725.17
    Metabolism/biosynthesis  
        Sulfite reductase flavoprotein subunit alpha035856.84
        Isopenicillin N synthase family oxygenase032022.20
        Ribonucleoside-diphosphate reductase subunit alpha020583.97
        N-Acetyltransferase001153.32
        Methylthioribulose 1-phosphate dehydratase012613.48
        Acyl-CoA dehydrogenase039473.15
    Cell division  
        Classical arabinogalactan protein 4034116.26
    Motility/attachment  
        Flagellin039062.41
Commonly downregulated genes  
        5S rRNA03698−6.82
a
The above-listed locus tags refer to the GenBank file CP060027 for isolate 454.
FIG 7
FIG 7 Functional distribution of commonly upregulated genes in biofilm cells of seven clinical S. maltophilia isolates. Isolates used for the transcriptome analysis were the clinical isolates SKK55, ICU331, 454, 677 PEG 13-68-68, PC239, and PC240. Fifty-two commonly upregulated genes (Table 5) were identified by a Venn analysis and classified by the function of their gene products.
Most interestingly, a hypothetical gene which is the corresponding homologue of smlt2713 in strain K279a was the most strongly and differentially expressed gene in all strains, with a log2 fold change of 10 to 12 (Fig. 6, region A, and Table S7). It carries a TbpB (transferrin-binding-protein) motif, implying that it is possibly involved in iron uptake. Notably, Tbp proteins have been associated with virulence in Actinobacillus pleuropneumoniae (49, 50). It is known that iron plays a role in biofilms of Bacillus subtilis (51) and S. maltophilia (22) as well as boosts biofilm formation of Staphylococcus aureus (52), P. aeruginosa (53), and Campylobacter jejuni (54). Further, a sulfite reductase gene was also upregulated in biofilm cells of all seven isolates, implying that the ability to assimilate sulfate and sulfite for energy conservation appears to be present in this organism. Furthermore, genes involved in nitrate transport and reduction were upregulated in four of the seven tested isolates (454, 677, ICU331, and PEG 13-68-68 [Fig. 6, region B]). This suggests an anaerobic mode of respiration in biofilm cells. Anaerobic respiration in biofilms has also been reported for P. aeruginosa (55, 56). Surprisingly, many motility affiliated genes were transcribed at elevated levels (Table S7). Domka and colleagues also demonstrated that the expression of some motility-related genes was increased in 7- to 24-h-old biofilms of Escherichia coli (57). Further studies have reported the involvement of flagella and pili in shaping the biofilm structures of P. aeruginosa and E. coli (5861). Thus, our findings may imply a similar function in S. maltophilia.
Furthermore, all isolates carry three copies of the ax21 genes, whereas for the reference strain K279a the presence of just two copies is known (smtl0387 and smtl0187). While two copies appeared to be strongly transcribed in biofilm cells of almost all seven isolates, a comparison with the planktonic cells implied that they are differentially transcribed in a strain-specific manner. In four of the seven tested isolates, the transcription of one or both copies of the ax21 gene was upregulated in biofilm cells (Table S7). The expression of the ax21 copies seems to be dependent on quorum sensing via the DSF in S. maltophilia (62). Nonetheless, its direct role in the biofilm formation by S. maltophilia remains unclear.
Notably, all analyzed S. maltophilia isolates code for at least four different cytochrome c oxidases. Under hypoxic conditions in biofilms, some of these cytochrome c oxidases were upregulated in some of the 7 isolates (Table S7), and a common cytochrome b oxidase was commonly upregulated in all isolates (Table 5).
Overall, with a proportion of 1.96% ± 1.02%, relatively few genes were downregulated in all seven investigated isolates. Generally, tRNAs and 5S and 16S rRNAs were downregulated in almost all analyzed isolates (Table S7). This indicates a reduced translation in biofilm cells in comparison to planktonic cells, which was already demonstrated, for instance, for Staphylococcus epidermidis, Clostridium perfringens, and Gardnerella vaginalis (6365).
Furthermore, some genes of a not-yet-characterized operon stretching from NIPOLPBK_01784 to NIPOLPBK_01792 (using the 454 nomenclature) were downregulated in all isolates. This operon codes for three hypothetical proteins, one membrane protein, one putative protease, two TldD proteins, and one MoxR-like-ATPase. TldD family proteins inhibit the DNA gyrase (66), and the MoxR-like-ATPase has chaperone-like functions (67). Moreover, a lysoplasmalogenase gene (NIPOLPBK_00344 in 454) was downregulated in four of the seven isolates. These enzymes form fatty aldehyde and glycerophosphoethanolamine or glycerophosphocholine by cleaving the vinyl ether bond of lysoplasmalogen (68, 69). These findings may imply a novel role of fatty acid and glycerol derivatives in the planktonic lifestyle.
Finally, on average, 1.16% ± 0.78% of all genes were strain-specifically upregulated and 0.56% ± 0.37% downregulated in the seven studied isolates. The majority of these genes are affiliated with metabolism (Table S8).

Conclusions.

Our study analyzed in detail a large number of S. maltophilia isolates with respect to biofilm forming capabilities, architecture, and metabolite production in biofilms, together with protease profiling and estimation of virulence in the G. mellonella model. Together, our data imply that within isolates of the species S. maltophilia an unexpected high phenotypic diversity exists. While strain specificity is a major challenge in S. maltophilia clinical research, we nevertheless have identified a set of 106 commonly and strongly expressed genes in biofilms and a maximum of 33 strain-specific genes.
Further, our data imply that, on average, 7.46% ± 1.49% of all genes were upregulated in biofilms versus planktonic cells and, on average, 1.96% ± 1.02% of all genes were downregulated.
The phenotypic and omics data generated in this study will provide a solid basis for further S. maltophilia biofilm studies and will help to reveal potential targets for the development of more effective drugs against this emerging pathogen.

MATERIALS AND METHODS

Bacterial strains, chemicals, and growth conditions.

Table S1 summarizes the S. maltophilia clinical and environmental isolates used in this study together with their metadata.
S. maltophilia strains were routinely cultured in LB medium (10 g/liter of tryptone, 5 g/liter of yeast extract, and 5 g/liter of NaCl) at 28°C or 37°C if not otherwise stated.

S. maltophilia biofilm assays.

(i) Static biofilm assay in microtiter plates. For analyses of static biofilms, S. maltophilia cells were grown in flat-bottomed microtiter plates (Nunc MicroWell, catalog no. 161093; Thermo Fisher Scientific, Waltham, MA) according to the method of Steinmann et al., with the following modifications (24). An overnight culture of S. maltophilia was adjusted to 4.0 × 107 cells/ml in LB medium. A total of 200 μl of the culture was pipetted in microtiter plates and incubated without shaking at 37°C for 24 h. After drying the biofilm, the adhered cells were stained with 50 μl of 0.5% crystal violet solution per well for 5 min and were washed three times with water afterwards. The plates were dried for 30 min at 37°C before crystal violet was dissolved in 150 μl of 33% acetic acid per well and the optical density at 595 nm (OD595) of the dye was measured. Six technical replicates were done per strain or condition. To obtain the relative biofilm OD value, we first measured the total OD (growth) value of each well in our microtiter plate assay and then set the crystal violet value in ratio to this, that is, value OD595 crystal violet/OD600 growth = relative biofilm OD value. Isolates with a relative biofilm OD of ≤0.2 were classified as weak biofilm formers, and isolates with a relative biofilm OD of ≥0.5 were classified as strong biofilm formers. All isolates between an OD of 0.2 and 0.5 were classified as moderate biofilm formers.
(ii) Cultivation of S. maltophilia biofilms in flow chambers or μ-slides. For analyses of the biofilm architecture, S. maltophilia isolates were cultivated in three-channel flow chambers (70) or eight-well μ-slide (ibiTreat, catalog no. 80826; ibidi USA Inc., Fitchburg, WI). All experiments were performed at 28°C with 10% LB medium. After 72 h, cells were stained using the LIVE/DEAD BacLight bacterial viability kit (Thermo Fisher Scientific, Waltham, MA) and the biofilm was analyzed by confocal microscopy.

Fluorescence imaging analysis of S. maltophilia biofilms.

Visualization of flow chamber and μ-slide biofilms was performed using a confocal laser scanning microscope (CLSM) Axio Observer.Z1/7 LSM 800 with airyscan (Carl Zeiss Microscopy GmbH, Jena, Germany) and a C-Apochromat 63×/1.20W Korr UV VisIR objective. The microscope settings for the different fluorescent dyes are shown in Table S2. The analysis of the CLSM images and three-dimensional reconstructions were done with ZEN software (version 2.3; Carl Zeiss Microscopy GmbH). Biofilm architecture was analyzed at least at three different positions for each strain, and one representative CLSM image was chosen. More detailed quantitative analyses of biofilm architecture, such as roughness and thickness, were done using BiofilmQ software version 0.1.4. (71) (https://drescherlab.org/data/biofilmQ/docs/usage/installation.html).

Galleria mellonella virulence assay.

The virulence of seven S. maltophilia isolates was tested using the Galleria mellonella model (72, 73). Final-instar larvae of G. mellonella were obtained from Biosystems Technology, Exeter, UK. Healthy larvae were identified by their cream color without dark discoloration and their vital movements. Prior to infection, the S. maltophilia isolates were grown in LB medium at 37°C to an OD600 of 0.5. Cells were washed twice in phosphate-buffered saline (PBS) and adjusted to 1 × 107/ml. For each isolate, an inoculum of 1 × 105 CFU/larva was then injected into the last proleg of the larvae. For each experiment, a total of 15 larvae were used for each isolate. A total of 15 larvae injected with 10 μl of PBS each served as a control. The larvae were then placed on Whatman paper-lined petri dishes and incubated at 37°C. The larvae were observed at 24, 48, and 72 h. Larvae were considered dead when no movement and a complete dark discoloration were observed.

Assessment of the extracellular proteolytic activity of biofilm and planktonic cultures.

For assessing the protease activity, we used the method as previously published by Steinmann et al., with minor modifications (24). For planktonic cultures, 30 ml of 10% LB (DWK Life Sciences GmbH, Westfalen, Germany) was inoculated with overnight cultures and placed to shake at 28°C to an OD600 of 0.5. Ten-milliliter aliquots of the cultures were pelleted at 4°C for 20 min. The supernatant was collected and sterile filtered (CA membrane, 0.2 μm). For biofilm cultures, overnight cultures were adjusted to an OD600 of 0.05 in 10% LB medium. The biofilm of four biological replicates was grown in 24-well microtiter plates (Nunc cell culture plate, catalog no. 142475; Thermo Fisher Scientific, Waltham, MA) at 28°C for 48 h. The supernatant was collected, centrifuged as described above, and sterile filtered. The protease activity was determined using the Molecular Probes EnzChek protease assay kit (Thermo Fisher Scientific). The protease activity of three technical replicates was measured in black BRANDplates microtiter plates with transparent bottoms (BRAND GmbH + Co. KG, Wertheim, Germany). A total of 100 μl of substrate, 90 μl of digestion buffer, and 10 μl of culture supernatant were pipetted into each well. Plates were incubated at 37°C and fluorescence was measured every 30 min in a Synergy HT plate reader (BioTek Instruments Inc., Winooski, VT) at 590/20-nm extinction and 645/40-nm emission wavelengths.

RNA-seq and data analysis.

RNA-seq was done as previously published, with minor modifications (74). For the preparation of cell material for RNA-seq analyses, biofilm cells were grown in flow cells as described above at 28°C for 72 h using 10% LB medium. To avoid contamination, media were supplemented with 50 μg/ml of ampicillin. Biofilms were grown in flow cells for 72 h and were washed out of the flow cells with a 20% stop mix (95% ethanol and 5% phenol) and pelleted at 4°C for 20 min. Planktonic cells were grown in 10% LB medium supplemented with 50 μg/ml of ampicillin at 28°C and were pelleted at the exponential phase (OD600 ∼ 0.5) at 4°C for 20 min. The pellets were frozen in liquid nitrogen for later analysis. Three biological replicates of each strain were prepared.
Harvested biofilm/planktonic cells were resuspended in 800 μl of RLT buffer from the RNeasy minikit (Qiagen, Hilden, Germany) with β-mercaptoethanol (10 μl/ml), and cell lysis was performed using a laboratory ball mill. Subsequently, 400 μl of RLT buffer (RNeasy minikit) with β-mercaptoethanol (10 μl/ml) and 1,200 μl of 96% [vol/vol] ethanol were added. For RNA isolation, the RNeasy minikit was used as recommended by the manufacturer, but instead of RW1 buffer, RWT buffer (Qiagen, Hilden, Germany) was used to also isolate RNAs smaller than 200 nucleotides (nt). To determine the RNA integrity number (RIN), the isolated RNA was run on an Agilent Bioanalyzer 2100 using an Agilent RNA 6000 Nano kit as recommended by the manufacturer (Agilent Technologies, Waldbronn, Germany). Remaining genomic DNA was removed by treating the samples with Turbo DNase (Thermo Fisher Scientific, Waltham, MA). Pan-Prokaryozes riboPOOL kit v1 (siTOOLS Biotech, Planegg/Martinsried, Germany) was used to reduce the amount of rRNA-derived sequences. For sequencing, the strand-specific cDNA libraries were constructed with a NEBNext Ultra II directional RNA library preparation kit for Illumina (New England BioLabs, Frankfurt am Main, Germany) using 50 ng of rRNA-depleted RNA and 8 PCR cycles. To assess the quality and size of the libraries, samples were run on an Agilent Bioanalyzer 2100 using an Agilent high-sensitivity DNA kit as recommended by the manufacturer (Agilent Technologies, Waldbronn, Germany). The concentrations of the libraries were determined using the Qubit double-stranded DNA (dsDNA) HS assay kit as recommended by the manufacturer (Life Technologies GmbH, Darmstadt, Germany). Sequencing was performed by using the HiSeq4000 or HiSeq2500 instrument (Illumina Inc., San Diego, CA) using either the HiSeq 3000/4000 SR cluster kit or the HiSeq Rapid PE cluster kit v2 for cluster generation and the HiSeq 3000/4000 SBS kit (50 cycles) for sequencing in the single-end mode and running 1 × 50 cycles. For quality filtering and removal of remaining adaptor sequences, Trimmomatic v-0.39 (75) and a cutoff phred-33 score of 15 were used. The mapping of the remaining sequences was performed with the Bowtie program (version 2) (76) using the implemented end-to-end mode, which requires that the entire reads align from one end to the other. Surviving reads were mapped against the reference genomes. NCBI GenBank numbers are listed at the end of the Materials and Methods section and in the footnote to Table 1. Reads per gene feature were counted using feature Counts v.2.0.0 (77). Subsequent analysis was performed in R (version 3.6.1) (78), including normalization of the reads with DeSeq2 (version 1.26.0) (79) using the default fold change-shrinkage algorithm. The rlog function with “blind” parameter set to TRUE within DeSeq2 was used for data transformation to generate principal-component analyses (PCAs), which were drawn with ggplot2 (version 3.2.1) (80), whereas the Enhanced Volcano packages (version 1.4.0) (81) were used for the creation of volcano plots.

Venn analysis.

Proteins with an identity of > 90% were combined in one cluster. Venn Painter tool (version 1.2.0) (82) was used to construct the Venn diagram and to identify the commonly expressed or regulated genes between the analyzed isolates.

Pangenome analysis.

Pangenome analysis and the illustration of the corresponding differential gene expression were conducted with Anvi’o 6.1 (83). Gene clusters were built with a minbit of 0.5. For the differential gene expression, gene clusters with a log2 fold change of greater than 2 were illustrated as upregulated and gene clusters with a log2 fold change of less than −2 were illustrated as downregulated.

Determination of metabolites via 1H NMR analyses.

For NMR analysis, the supernatant of biofilm cultures grown in flow cells for 72 h in 10% LB medium at 28°C was collected. Samples were mixed with 40 mM phosphate buffer (K2HPO4 and KH2PO4 in H2O) in a ratio of 1:9 (sample to buffer). A standard (trimethylsilylpropanoic acid [TMSP], 5 mM) was also added. The 1H NMR samples were measured with an excitation sculpting sequence for water suppression with a 600-MHz spectrometer with 128 scans at 300 K. A total of 65,536 data points and a spectral width of 16.0221 ppm was acquired with the O1 at the signal of water at 2,819 Hz. All spectra were processed with Topspin version 4.0.8, applying an exponential multiplication of the free induction decay (FID) with a line broadening factor of 0.3 Hz.

Data availability.

The raw reads of the 42 mRNA sequencing runs have been deposited in the SRA nucleotide archive under BioProject no. PRJNA646397 and correspond to the SRA accession numbers SRX8752168 to SRX8752209. Updated GenBank files of the genomes of the seven isolates included in the transcriptome analyses were submitted under the following identifiers (IDs) and accession numbers: UHH_SKK55, CP060025; UHH_ICU331, CP060026; UHH_677, CP060024; UHH_454, CP060027; UHH_PC239, CP060023; UHH_PC240, CP060022; and UHH_PEG13-68-68, CP060021.

ACKNOWLEDGMENTS

This work was funded by the Rahn-Quade-Stiftung, Universität Hamburg, and DFG funding project INST 152/778-1-FUGG.
We thank Sabrina Bielfeld and Raphael Moll for technical assistance.
I.A., M.G., and W.R.S. conceived the study. I.A., M.G., A.P., M.C.S., and J.H. generated the data. P.P.G., A.P., R.E., and D.D. performed the bioinformatics analyses. W.R.S. acquired funding. W.R.S., D.Y., J.S., T.A.K., and I.G. provided resources for this study. I.A., M.G., A.P., R.E., P.P.G., and J.H. visualized the results. I.A., M.G., and W.R.S. wrote the initial draft. All authors critically reviewed and modified the paper.
Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany, is one of the Hamburg-Lübeck-Borstel-Riems partner sites of the German Center for Infection Research (DZIF).

Supplemental Material

File (aem.02038-20-s0001.pdf)
File (aem.02038-20-s0002-original_table_s1.xlsx)
File (aem.02038-20-s0004.xlsx)
File (aem.02038-20-s0005.xlsx)
File (aem.02038-20-s0006.xlsx)
File (aem.02038-20-s0007.xlsx)
File (aem.02038-20-s0008.xlsx)
File (aem.02038-20-s0009.xlsx)
File (aem.02038-20-s00d3.xlsx)
File (aem.02038-20_revised_table_s1.xlsx)
ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse.

REFERENCES

1.
Brooke JS, Di Bonaventura G, Berg G, Martinez JL. 2017. Editorial: a multidisciplinary look at Stenotrophomonas maltophilia: an emerging multi-drug-resistant global opportunistic pathogen. Front Microbiol 8:1511.
2.
Denton M, Kerr KG. 1998. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 11:57–80.
3.
Adegoke AA, Stenstrom TA, Okoh AI. 2017. Stenotrophomonas maltophilia as an emerging ubiquitous pathogen: looking beyond contemporary antibiotic therapy. Front Microbiol 8:2276.
4.
Goss CH, Mayer-Hamblett N, Aitken ML, Rubenfeld GD, Ramsey BW. 2004. Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis. Thorax 59:955–959.
5.
Coutinho HD, Falcao-Silva VS, Goncalves GF. 2008. Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers. Int Arch Med 1:24.
6.
Chawla K, Vishwanath S, Gupta A. 2014. Stenotrophomonas maltophilia in lower respiratory tract infections. J Clin Diagn Res 8:DC20–2.
7.
Samonis G, Karageorgopoulos DE, Maraki S, Levis P, Dimopoulou D, Spernovasilis NA, Kofteridis DP, Falagas ME. 2012. Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome. PLoS One 7:e37375.
8.
Bostanghadiri N, Ghalavand Z, Fallah F, Yadegar A, Ardebili A, Tarashi S, Pournajaf A, Mardaneh J, Shams S, Hashemi A. 2019. Characterization of phenotypic and genotypic diversity of Stenotrophomonas maltophilia strains isolated from selected hospitals in Iran. Front Microbiol 10:1191.
9.
Pompilio A, Crocetta V, Ghosh D, Chakrabarti M, Gherardi G, Vitali LA, Fiscarelli E, Di Bonaventura G. 2016. Stenotrophomonas maltophilia phenotypic and genotypic diversity during a 10-year colonization in the lungs of a cystic fibrosis patient. Front Microbiol 7:1551.
10.
Abda EM, Krysciak D, Krohn-Molt I, Mamat U, Schmeisser C, Forstner KU, Schaible UE, Kohl TA, Nieman S, Streit WR. 2015. Phenotypic heterogeneity affects Stenotrophomonas maltophilia K279a colony morphotypes and beta-lactamase expression. Front Microbiol 6:1373.
11.
Gröschel MI, Meehan CJ, Barilar I, Diricks M, Gonzaga A, Steglich M, Conchillo-Sole O, Scherer IC, Mamat U, Luz CF, De Bruyne K, Utpatel C, Yero D, Gibert I, Daura X, Kampmeier S, Rahman NA, Kresken M, van der Werf TS, Alio I, Streit WR, Zhou K, Schwartz T, Rossen JWA, Farhat MR, Schaible UE, Nubel U, Rupp J, Steinmann J, Niemann S, Kohl TA. 2020. The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia. Nat Commun 11:2044.
12.
Zgair AK, Chhibber S. 2011. Adhesion of Stenotrophomonas maltophilia to mouse tracheal mucus is mediated through flagella. J Med Microbiol 60:1032–1037.
13.
de Oliveira-Garcia D, Dall’Agnol M, Rosales M, Azzuz ACGS, Alcántara N, Martinez MB, Girón JA. 2003. Fimbriae and adherence of Stenotrophomonas maltophilia to epithelial cells and to abiotic surfaces. Cell Microbiol 5:625–636.
14.
Pompilio A, Crocetta V, Confalone P, Nicoletti M, Petrucca A, Guarnieri S, Fiscarelli E, Savini V, Piccolomini R, Di Bonaventura G. 2010. Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. BMC Microbiol 10:102.
15.
Boisvert AA, Cheng MP, Sheppard DC, Nguyen D. 2016. Microbial biofilms in pulmonary and critical care diseases. Ann Am Thorac Soc 13:1615–1623.
16.
Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318–1322.
17.
Alcaraz E, Garcia C, Friedman L, de Rossi BP. 2019. The rpf/DSF signalling system of Stenotrophomonas maltophilia positively regulates biofilm formation, production of virulence-associated factors and beta-lactamase induction. FEMS Microbiol Lett 366:fnz069.
18.
Huedo P, Yero D, Martinez-Servat S, Estibariz I, Planell R, Martinez P, Ruyra A, Roher N, Roca I, Vila J, Daura X, Gibert I. 2014. Two different rpf clusters distributed among a population of Stenotrophomonas maltophilia clinical strains display differential diffusible signal factor production and virulence regulation. J Bacteriol 196:2431–2442.
19.
Kang XM, Wang FF, Zhang H, Zhang Q, Qiana W. 2015. Genome-wide identification of genes necessary for biofilm formation by nosocomial pathogen Stenotrophomonas maltophilia reveals that orphan response regulator FsnR is a critical modulator. Appl Environ Microbiol 81:1200–1209.
20.
Huang TP, Somers EB, Wong AC. 2006. Differential biofilm formation and motility associated with lipopolysaccharide/exopolysaccharide-coupled biosynthetic genes in Stenotrophomonas maltophilia. J Bacteriol 188:3116–3120.
21.
Zhuo C, Zhao QY, Xiao SN. 2014. The impact of spgM, rpfF, rmlA gene distribution on biofilm formation in Stenotrophomonas maltophilia. PLoS One 9:e108409.
22.
Garcia CA, Alcaraz ES, Franco MA, Passerini de Rossi BN. 2015. Iron is a signal for Stenotrophomonas maltophilia biofilm formation, oxidative stress response, OMPs expression, and virulence. Front Microbiol 6:926.
23.
Kalidasan V, Joseph N, Kumar S, Awang Hamat R, Neela VK. 2018. Iron and virulence in Stenotrophomonas maltophilia: all we know so far. Front Cell Infect Microbiol 8:401.
24.
Steinmann J, Mamat U, Abda EM, Kirchhoff L, Streit WR, Schaible UE, Niemann S, Kohl TA. 2018. Analysis of phylogenetic variation of Stenotrophomonas maltophilia reveals human-specific branches. Front Microbiol 9:806.
25.
Di Bonaventura G, Spedicato I, D’Antonio D, Robuffo I, Piccolomini R. 2004. Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime. Antimicrob Agents Chemother 48:151–160.
26.
Guilbaud M, Piveteau P, Desvaux M, Brisse S, Briandet R. 2015. Exploring the diversity of Listeria monocytogenes biofilm architecture by high-throughput confocal laser scanning microscopy and the predominance of the honeycomb-like morphotype. Appl Environ Microbiol 81:1813–1819.
27.
Deligianni E, Pattison S, Berrar D, Ternan NG, Haylock RW, Moore JE, Elborn SJ, Dooley JS. 2010. Pseudomonas aeruginosa cystic fibrosis isolates of similar RAPD genotype exhibit diversity in biofilm forming ability in vitro. BMC Microbiol 10:38.
28.
Hornischer K, Khaledi A, Pohl S, Schniederjans M, Pezoldt L, Casilag F, Muthukumarasamy U, Bruchmann S, Thoming J, Kordes A, Haussler S. 2019. BACTOME—a reference database to explore the sequence- and gene expression-variation landscape of Pseudomonas aeruginosa clinical isolates. Nucleic Acids Res 47:D716–D720.
29.
Lee S, Engel JMH, Caballero AR, Green LC, O’Callaghan RJ. 1998. Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosa. J Biol Chem 273:16792–16797.
30.
Ashley L, DuMont NPC. 2017. Stenotrophomonas maltophilia serine protease StmPr1 induces matrilysis, anoikis, and protease-activated receptor 2 activation in human lung epithelial cells. Infect Immun 85:e00544-17.
31.
Brunder W, Schmidt H, Karch H. 1997. EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157-H7 cleaves human coagulation factor V. Mol Microbiol 24:767–778.
32.
Connelly MB, Young GM, Sloma A. 2004. Extracellular proteolytic activity plays a central role in swarming motility in Bacillus subtilis. J Bacteriol 186:4159–4167.
33.
Adamek M, Overhage J, Bathe S, Winter J, Fischer R, Schwartz T. 2011. Genotyping of environmental and clinical Stenotrophomonas maltophilia isolates and their pathogenic potential. PLoS One 6:e27615.
34.
Nicoletti M, Iacobino A, Prosseda G, Fiscarelli E, Zarrilli R, De Carolis E, Petrucca A, Nencioni L, Colonna B, Casalino M. 2011. Stenotrophomonas maltophilia strains from cystic fibrosis patients: genomic variability and molecular characterization of some virulence determinants. Int J Med Microbiol 301:34–43.
35.
McMillan M, Pereg L. 2014. Evaluation of reference genes for gene expression analysis using quantitative RT-PCR in Azospirillum brasilense. PLoS One 9:e98162.
36.
Krzyżanowska DM, Supernat A, Maciąg T, Matuszewska M, Jafra S. 2019. Selection of reference genes for measuring the expression of aiiO in Ochrobactrum quorumnocens A44 using RT-qPCR. Sci Rep 9:13129.
37.
Thomas LM, Harper AR, Miner WA, Ajufo HO, Branscum KM, Kao L, Sims PA. 2013. Structure of Escherichia coli AdhP (ethanol-inducible dehydrogenase) with bound NAD. Acta Crystallogr Sect F Struct Biol Cryst Commun 69:730–732.
38.
Bouveret E, Bénédetti H, Rigal A, Loret E, Lazdunski C. 1999. In vitro characterization of peptidoglycan-associated lipoprotein (PAL)-peptidoglycan and PAL-TolB interactions. J Bacteriol 181:6306–6311.
39.
Godlewska R, Wiśniewska K, Pietras Z, Jagusztyn-Krynicka EK. 2009. Peptidoglycan-associated lipoprotein (Pal) of Gram-negative bacteria: function, structure, role in pathogenesis and potential application in immunoprophylaxis. FEMS Microbiol Lett 298:1–11.
40.
Wang C, Li M, Dong D, Wang J, Ren J, Otto M, Gao Q. 2007. Role of ClpP in biofilm formation and virulence of Staphylococcus epidermidis. Microbes Infect 9:1376–1383.
41.
Xie F, Zhang Y, Li G, Zhou L, Liu S, Wang C. 2013. The ClpP protease is required for the stress tolerance and biofilm formation in Actinobacillus pleuropneumoniae. PLoS One 8:e53600.
42.
Inamine GS, Dubnau D. 1995. ComEA, a Bacillus subtilis integral membrane protein required for genetic transformation, is needed for both DNA binding and transport. J Bacteriol 177:3045–3051.
43.
Petersen FC, Tao L, Scheie AA. 2005. DNA binding-uptake system: a link between cell-to-cell communication and biofilm formation. J Bacteriol 187:4392–4400.
44.
Gueiros-Filho FJ, Losick R. 2002. A widely conserved bacterial cell division protein that promotes assembly of the tubulin-like protein FtsZ. Genes Dev 16:2544–2556.
45.
Galli E, Gerdes K. 2012. FtsZ-ZapA-ZapB interactome of Escherichia coli. J Bacteriol 194:292–302.
46.
Roach EJ, Kimber MS, Khursigara CM. 2014. Crystal structure and site-directed mutational analysis reveals key residues involved in Escherichia coli ZapA function. J Biol Chem 289:23276–23286.
47.
Eraso JM, Markillie LM, Mitchell HD, Taylor RC, Orr G, Margolin W. 2014. The highly conserved MraZ protein is a transcriptional regulator in Escherichia coli. J Bacteriol 196:2053–2066.
48.
Fisunov GY, Evsyutina DV, Semashko TA, Arzamasov AA, Manuvera VA, Letarov AV, Govorun VM. 2016. Binding site of MraZ transcription factor in Mollicutes. Biochimie 125:59–65.
49.
Baltes N, Hennig-Pauka I, Gerlach GF. 2002. Both transferrin binding proteins are virulence factors in Actinobacillus pleuropneumoniae serotype 7 infection. FEMS Microbiol Lett 209:283–287.
50.
Adamiak P, Calmettes C, Moraes TF, Schryvers AB. 2015. Patterns of structural and sequence variation within isotype lineages of the Neisseria meningitidis transferrin receptor system. Microbiologyopen 4:491–504.
51.
Pisithkul T, Schroeder JW, Trujillo EA, Yeesin P, Stevenson DM, Chaiamarit T, Coon JJ, Wang JD, Amador-Noguez D. 2019. Metabolic remodeling during biofilm development of Bacillus subtilis. mBio 10:e00623-19.
52.
Lin MH, Shu JC, Huang HY, Cheng YC. 2012. Involvement of iron in biofilm formation by Staphylococcus aureus. PLoS One 7:e34388.
53.
Banin E, Vasil ML, Greenberg EP. 2005. Iron and Pseudomonas aeruginosa biofilm formation. Proc Natl Acad Sci U S A 102:11076–11081.
54.
Oh E, Andrews KJ, Jeon B. 2018. Enhanced biofilm formation by ferrous and ferric iron through oxidative stress in Campylobacter jejuni. Front Microbiol 9:1204.
55.
Yoon SS, Hennigan RF, Hilliard GM, Ochsner UA, Parvatiyar K, Kamani MC, Allen HL, DeKievit TR, Gardner PR, Schwab U, Rowe JJ, Iglewski BH, McDermott TR, Mason RP, Wozniak DJ, Hancock REW, Parsek MR, Noah TL, Boucher RC, Hassett DJ. 2002. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev Cell 3:593–603.
56.
Van Alst NE, Picardo KF, Iglewski BH, Haidaris CG. 2007. Nitrate sensing and metabolism modulate motility, biofilm formation, and virulence in Pseudomonas aeruginosa. Infect Immun 75:3780–3790.
57.
Domka J, Lee J, Bansal T, Wood TK. 2007. Temporal gene-expression in Escherichia coli K-12 biofilms. Environ Microbiol 9:332–346.
58.
Klausen M, Aaes-Jorgensen A, Molin S, Tolker-Nielsen T. 2003. Involvement of bacterial migration in the development of complex multicellular structures in Pseudomonas aeruginosa biofilms. Mol Microbiol 50:61–68.
59.
Klausen M, Heydorn A, Ragas P, Lambertsen L, Aaes-Jørgensen A, Molin S, Tolker-Nielsen T. 2003. Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol Microbiol 48:1511–1524.
60.
Shrout JD, Chopp DL, Just CL, Hentzer M, Givskov M, Parsek MR. 2006. The impact of quorum sensing and swarming motility on Pseudomonas aeruginosa biofilm formation is nutritionally conditional. Mol Microbiol 62:1264–1277.
61.
Wood TK, Gonzalez Barrios AF, Herzberg M, Lee J. 2006. Motility influences biofilm architecture in Escherichia coli. Appl Microbiol Biotechnol 72:361–367.
62.
Devos S, Van Oudenhove L, Stremersch S, Van Putte W, De Rycke R, Van Driessche G, Vitse J, Raemdonck K, Devreese B. 2015. The effect of imipenem and diffusible signaling factors on the secretion of outer membrane vesicles and associated Ax21 proteins in Stenotrophomonas maltophilia. Front Microbiol 6:298.
63.
Daniel E, Sturdevant MO, Yao Y. 2005. Genomewide analysis of gene expression in Staphylococcus epidermidis biofilms: insights into the pathophysiology of S. epidermidis biofilms and the role of phenol-soluble modulins in formation of biofilms. J Infect Dis 191:289–298.
64.
Charlebois A, Jacques M, Archambault M. 2016. Comparative transcriptomic analysis of Clostridium perfringens biofilms and planktonic cells. Avian Pathol 45:593–601.
65.
Castro J, Franca A, Bradwell KR, Serrano MG, Jefferson KK, Cerca N. 2017. Comparative transcriptomic analysis of Gardnerella vaginalis biofilms vs. planktonic cultures using RNA-seq. NPJ Biofilms Microbiomes 3:3.
66.
Murayama N, Shimizu H, Takiguchi S, Baba Y, Amino H, Horiuchi T, Sekimizu K, Miki T. 1996. Evidence for involvement of Escherichia coli genes pmbA, csrA and a previously unrecognized gene tldD, in the control of DNA gyrase by letD (ccdB) of sex factor F. J Mol Biol 256:483–502.
67.
Snider J, Houry WA. 2006. MoxR AAA+ ATPases: a novel family of molecular chaperones? J Struct Biol 156:200–209.
68.
Jurkowitz-Alexander M, Ebata H, Mills JS, Murphy EJ, Horrocks LA. 1989. Solubitization, purification and characterization of lysoplasrnalogen alkenylhydrolase (lysoplasrnalogenase) from rat liver microsomes. Biochim Biophys Acta 1002:203–212.
69.
Wu LC, Pfeiffer DR, Calhoon EA, Madiai F, Marcucci G, Liu S, Jurkowitz MS. 2011. Purification, identification, and cloning of lysoplasmalogenase, the enzyme that catalyzes hydrolysis of the vinyl ether bond of lysoplasmalogen. J Biol Chem 286:24916–24930.
70.
Tolker-Nielsen T, Sternberg C. 2011. Growing and analyzing biofilms in flow chambers. Curr Protoc Microbiol Chapter 1:Unit 1B2.
71.
Hartmann R, Jeckel H, Jelli E, Singh PK, Vaidya S, Bayer M, Vidakovic L, Diaz-Pascual F, Fong JCN, Dragos A, Besharova O, Nadell CD, Sourjik V, Kovacs AT, Yildiz FH, Drescher K. 2019. BiofilmQ, a software tool for quantitative image analysis of microbial biofilm communities. bioRxiv.
72.
Ramarao N, Nielsen-Leroux C, Lereclus D. 2012. The insect Galleria mellonella as a powerful infection model to investigate bacterial pathogenesis. J Vis Exp 2012:e4392.
73.
Tsai CJ, Loh JM, Proft T. 2016. Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing. Virulence 7:214–229.
74.
Gao R, Krysciak D, Petersen K, Utpatel C, Knapp A, Schmeisser C, Daniel R, Voget S, Jaeger KE, Streit WR. 2015. Genome-wide RNA sequencing analysis of quorum sensing-controlled regulons in the plant-associated Burkholderia glumae PG1 strain. Appl Environ Microbiol 81:7993–8007.
75.
Bolger AM, Lohse M, Usadel B. 2014. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114–2120.
76.
Langmead B, Salzberg SL. 2012. Fast gapped-read alignment with Bowtie 2. Nat Methods 9:357–359.
77.
Liao Y, Smyth GK, Shi W. 2014. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30:923–930.
78.
R Core Team. 2020. A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
79.
Love MI, Huber W, Anders S. 2014. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550.
80.
Wickham H. 2016. ggplot2: elegant graphics for data analysis. Springer-Verlag New York, New York, NY.
81.
Blighe KR, Lewis M. 2019. EnhancedVolcano: publication-ready volcano plots with enhanced colouring and labeling. Bioconductor: Open Source Software for Bioinformatics.
82.
Lin G, Chai J, Yuan S, Mai C, Cai L, Murphy RW, Zhou W, Luo J. 2016. VennPainter: a tool for the comparison and identification of candidate genes based on Venn diagrams. PLoS One 11:e0154315.
83.
Eren AM, Esen OC, Quince C, Vineis JH, Morrison HG, Sogin ML, Delmont TO. 2015. Anvi’o: an advanced analysis and visualization platform for ‘omics data. PeerJ 3:e1319.

Information & Contributors

Information

Published In

cover image Applied and Environmental Microbiology
Applied and Environmental Microbiology
Volume 86Number 2424 November 2020
eLocator: e02038-20
Editor: Robert M. Kelly, North Carolina State University
PubMed: 33097507

History

Received: 25 August 2020
Accepted: 4 October 2020
Published online: 24 November 2020

Keywords

  1. Stenotrophomonas
  2. transcriptome
  3. biofilms

Notes

A note regarding the Supplemental Material: The original Table S1 used incorrect coordinates with regard to Fig. 1 in the main text. Revised supplemental material was posted online 17 July 2021

Contributors

Authors

Department of Microbiology and Biotechnology, Universität Hamburg, Hamburg, Germany
Mirja Gudzuhn
Department of Microbiology and Biotechnology, Universität Hamburg, Hamburg, Germany
Department of Microbiology and Biotechnology, Universität Hamburg, Hamburg, Germany
Dominik Danso
Department of Microbiology and Biotechnology, Universität Hamburg, Hamburg, Germany
Marie Charlotte Schoelmerich
Department of Microbiology and Biotechnology, Universität Hamburg, Hamburg, Germany
Uwe Mamat
Molecular and Experimental Mycobacteriology, Priority Area Infections, Research Center Borstel, Borstel, Germany
Ulrich E. Schaible
Molecular and Experimental Mycobacteriology, Priority Area Infections, Research Center Borstel, Borstel, Germany
Jörg Steinmann
Institut für Klinikhygiene, Medizinische Mikrobiologie und Klinische Infektiologie, Universitätsinstitut der Paracelsus Medizinischen Privatuniversität Klinikum Nürnberg, Nürnberg, Germany
Daniel Yero
Department of Genetics and Microbiology and Institute of Biotechnology and Biomedicine, Universitat Autònoma de Barcelona, Barcelona, Spain
Department of Genetics and Microbiology and Institute of Biotechnology and Biomedicine, Universitat Autònoma de Barcelona, Barcelona, Spain
Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany
Stefan Niemann
Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany
Matthias I. Gröschel
Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA
Johanna Haerdter
Institute of Organic Chemistry, Universität Hamburg, Hamburg, Germany
Thomas Hackl
Institute of Organic Chemistry, Universität Hamburg, Hamburg, Germany
Christel Vollstedt
Department of Microbiology and Biotechnology, Universität Hamburg, Hamburg, Germany
Mechthild Bömeke
Institute of Microbiology and Genetics, Department of Genomic and Applied Microbiology, Georg-August University of Göttingen, Göttingen, Germany
Richard Egelkamp
Institute of Microbiology and Genetics, Department of Genomic and Applied Microbiology, Georg-August University of Göttingen, Göttingen, Germany
Institute of Microbiology and Genetics, Department of Genomic and Applied Microbiology, Georg-August University of Göttingen, Göttingen, Germany
Institute of Microbiology and Genetics, Department of Genomic and Applied Microbiology, Georg-August University of Göttingen, Göttingen, Germany
Department of Microbiology and Biotechnology, Universität Hamburg, Hamburg, Germany

Editor

Robert M. Kelly
Editor
North Carolina State University

Notes

Address correspondence to Ifey Alio, [email protected], or Wolfgang R. Streit, [email protected].
Ifey Alio and Mirja Gudzuhn are co-first authors and made equal contributions. Ifey Alio was involved in conceptualization of the study and establishing methods used and equally contributed to the experiments.

Metrics & Citations

Metrics

Note:

  • For recently published articles, the TOTAL download count will appear as zero until a new month starts.
  • There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.
  • Citation counts come from the Crossref Cited by service.

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

View Options

Figures and Media

Figures

Media

Tables

Share

Share

Share the article link

Share with email

Email a colleague

Share on social media

American Society for Microbiology ("ASM") is committed to maintaining your confidence and trust with respect to the information we collect from you on websites owned and operated by ASM ("ASM Web Sites") and other sources. This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.
FIND OUT MORE about the privacy policy